prochlorperazine has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 1 studies
Prochlorperazine: A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)
prochlorperazine : A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clemons, A | 1 |
| Vasiadi, M | 1 |
| Kempuraj, D | 1 |
| Kourelis, T | 1 |
| Vandoros, G | 1 |
| Theoharides, TC | 1 |
1 other study available for prochlorperazine and Chronic Fatigue and Immune Dysfunction Syndrome
| Article | Year |
|---|---|
Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome.
Topics: Amitriptyline; Cells, Cultured; Fatigue Syndrome, Chronic; Humans; Inflammation Mediators; Mast Cell | 2011 |